Abstract
The rhizome of Atractylodes japonica Koidzumi (AJK) has been used in traditional medicine for treatment of arthritis, bronchitis and respiratory infectious disease, whereas its effects on inflammatory reactions have not been unknown recently. In this study, the effects of AJK on allergic inflammation and its signaling were investigated in the induced human mast cells and animal model. This study showed that ethanol extract of AJK interestingly suppressed the production and mRNA expression of TNF-α, IL-6 and IL-8, as important inflammatory cytokines. Furthermore, AJK inhibited the nuclear translocation of nuclear factor (NF)-κB through inhibition of the phosphorylation of IB-κ, which was additionally elucidated by NF-κB promoter-mediated luciferase activity. In addition, the phosphorylation of ERK was increased in pretreatment with AJK, whereas there was no change in JNK and p38 MAPK. However, AJK showed no effects on anti-DNP IgE-mediated in vivo PCA reaction and histamine release, as key events of mast cell-mediated immediate allergic reactions. These results suggest that AJK might be involved in not early-phase but transition to late-phase reactions of allergic inflammation and could modulate through other signal pathways. Taken together, AJK could be used as a treatment for mast cell mediated late-phase/chronic allergic inflammatory reactions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baldwin, A. S. Jr., The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol., 14, 649–683 (1996).
Bischoff, S. C., Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat. Rev. Immunol., 7, 93–104 (2007).
Choi, E. M., Kim, G. H., and Lee, Y. S., Atractylodes japonica root extract protects osteoblastic MC3T3-E1 cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation. Phytother. Res., In press.
Choi, I. W., Kim, Y. S., Kim, D. K., Choi, J. H., Seo, K. H., Im, S. Y., Kwon, K. S., Lee, M. S., Ha, T. Y., and Lee, H. K., Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction. J. Exp. Med., 198, 145–151 (2003).
Choi, I. W., Sun, K., Kim, Y. S., Ko, H. M., Im, S. Y., Kim, J. H., You, H. J., Lee, Y. C., Lee, J. H., Park, Y. M., and Lee, H. K., TNF-alpha induces the late-phase airway hyper-responsiveness and airway inflammation through cytosolic phospholipase A(2) activation. J. Allergy Clin. Immunol., 116, 537–543 (2005).
Collins, T. and Cybulsky, M. I., NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?. J. Clin. Invest., 107, 255–264 (2001).
Cruse, G., Kaur, D., Yang, W., Duffy, S. M., Brightling, C. E., and Bradding, P., Activation of human lung mast cells by monomeric immunoglobulin E. Eur. Respir. J., 25, 858–863 (2005).
Dong, H., He, L., Huang, M., and Dong, Y., Anti-inflammatory components isolated from Atractylodes macrocephala Koidz. Nat. Prod. Res., 22, 1418–1427 (2008).
Duan, W. and Wong, W. S., Targeting mitogen-activated protein kinases for asthma. Curr. Drug Targets, 7, 691–698 (2006).
Galli, S. J., Tsai, M., and Piliponsky, A. M., The development of allergic inflammation. Nature, 454, 445–454 (2008).
Gilfillan, A. M. and Tkaczyk, C., Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol., 6, 218–230 (2006).
Hachisuka, H., Kusuhara, M., Higuchi, M., Okubo, K., and Sasai, Y., Purification of rat cutaneous mast cells with Percoll density centrifugation. Arch. Dermatol. Res., 280, 358–362 (1988).
Han, S. B., Lee, C. W., Yoon, Y. D., Lee, J. H., Kang, J. S., Lee, K. H., Yoon, W. K., Lee, K., Park, S. K., and Kim, H. M., Prevention of arthritic inflammation using an oriental herbal combination BDX-1 isolated from Achyranthes bidentata and Atractylodes japonica. Arch. Pharm. Res., 28, 902–908 (2005).
Harada, M., Nagata, M., and Takeuchi, M., Production of passive cutaneous anaphylaxis (PCA) and reversed PCA by rat IgE antibody in the mouse. Experientia, 44, 459–462 (1988).
Jang, M. H., Shin, M. C., Kim, Y. J., Kim, C. J., Kim, Y., and Kim, E. H., Atractylodes japonica suppresses lipopoly-saccharide-stimulated expressions of inducible nitric oxide synthase and cyclooxygenase-2 in RAW 264.7 macrophages. Biol. Pharm. Bull., 27, 324–327 (2004).
Jobin, C., Bradham, C. A., Russo, M. P., Juma, B., Narula, A. S., Brenner, D. A., and Sartor, R. B., Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor Ikappa B kinase activity. J. Immunol., 163, 3474–3483 (1999).
Karin, M. and Ben-Neriah, Y., Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol., 18, 621–663 (2000).
Kim, S. J., Lee, E. J., Song, Y. S., Jeong, H. J., Lee, K. M., Kim, H. R., Chae, H. J., Shin, T. Y., Kim, Y. K., Hong, S. H., and Kim, H. M., Cheongyeolsaseuptang inhibits production of TNF-alpha, IL-6 and IL-8 as well as NF-kappa B activation in human mast cells. J. Ethnopharmacol., 97, 83–88 (2005).
Kyriakis, J. M. and Avruch, J., Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem., 271, 24313–24316 (1996).
Li, C. Q., He, L. C., and Jin, J. Q., Atractylenolide I and atractylenolide III inhibit Lipopolysaccharide-induced TNF-alpha and NO production in macrophages. Phytother. Res., 21, 347–353 (2007).
Lippert, U., Moller, A., Welker, P., Artuc, M., and Henz, B. M., Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp. Dermatol., 9, 118–124 (2000).
Mekori, Y. A. and Metcalfe, D. D., Mast cells in innate immunity. Immunol. Rev., 173, 131–140 (2000).
Mican, J. A., Arora, N., Burd, P. R., and Metcalfe, D. D., Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J. Allergy Clin. Immunol., 90, 815–824 (1992).
Min, B. S., Kim, Y. H., Tomiyama, M., Nakamura, N., Miyashiro, H., Otake, T., and Hattori, M., Inhibitory effects of Korean plants on HIV-1 activities. Phytother. Res., 15, 481–486 (2001).
Prussin, C. and Metcalfe, D. D., 4. IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol., 111, S486–S494 (2003).
Satoh, K., Nagai, F., Ushiyama, K., and Kano, I., Specific inhibition of Na+,K(+)-ATPase activity by atractylon, a major component of byaku-jutsu, by interaction with enzyme in the E2 state. Biochem. Pharmacol., 51, 339–343 (1996).
Valenta, R., The future of antigen-specific immunotherapy of allergy. Nat. Rev. Immunol., 2, 446–453 (2002).
Wong, C. K., Tsang, C. M., Ip, W. K., and Lam, C. W., Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-alpha: roles of ERK, p38 MAPK, and NFkappaB. Allergy, 61, 289–297 (2006).
Wong, W. S. and Koh, D. S., Advances in immunopharmacology of asthma. Biochem. Pharmacol., 59, 1323–1335 (2000).
Yamamoto, Y., Yin, M. J., Lin, K. M., and Gaynor, R. B., Sulindac inhibits activation of the NF-kappaB pathway. J. Biol. Chem., 274, 27307–27314 (1999).
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors equally contributed to this work
Rights and permissions
About this article
Cite this article
Hong, M.H., Kim, JH., Bae, H. et al. Atractylodes japonica Koidzumi inhibits the production of proinflammatory cytokines through inhibition of the NF-κB/IκB signal pathway in HMC-1 human mast cells. Arch. Pharm. Res. 33, 843–851 (2010). https://doi.org/10.1007/s12272-010-0606-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0606-6